Health
Antigenic “supersite” could improve design of COVID-19 vaccines – News-Medical.Net
Researchers in the United States have defined an antigenic “supersite” within the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could…
Researchers in the United States have defined an antigenic “supersite” within the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could have important implications for the design of vaccines to protect against coronavirus disease 2019 (COVID-19).
The site was identified on the N-terminal domain (NTD) of the viral spike protein – the main structure the virus uses to bind and infect host cells.
The team – from Columbia University and the National Institute of Allergy and Infectious…
-
Business23 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General22 hours agoFederal government funding extends cohealth GP services until July 2026
-
General6 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News20 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region